Ralph William Charlton III
Equibles does not estimate personal net worth.
About Ralph William Charlton III
Spruce Biosciences, Inc. reported in an 8-K filed December 27, 2024 that Ralph William Charlton III was terminated as Chief Medical Officer, effective December 31, 2024. The proxy statement of Spruce Biosciences, Inc. reports total compensation of $1,161,336 for Ralph William Charlton III in fiscal 2024, including a base salary of $457,600. Disclosed compensation is on record for 4 fiscal years.
“On December 20, 2024, Spruce Biosciences, Inc. (the “Company”) announced that the employment of Ralph William Charlton III, M.D., M.A.S, will cease as of December 31, 2024.”
Affiliation history
-
Spruce Biosciences, Inc. (SPRB)
Proxy statement
Start not stated–2024-12-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Spruce Biosciences, Inc. (SPRB) | M.D., M.A.S. Former Chief Medical Officer | $457,600 | $1,161,336 |
| 2023 | Spruce Biosciences, Inc. (SPRB) | M.D., M.A.S. Former Chief Medical Officer | $440,000 | $1,004,904 |
| 2022 | Spruce Biosciences, Inc. (SPRB) | M.D., M.A.S. Chief Medical Officer | $305,556 | $962,358 |
| 2021 | Spruce Biosciences, Inc. (SPRB) | M.D., M.A.S. Chief Medical Officer | — | — |